Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole.
Grant
Marni J
MJ
Baldessarini
Ross J
RJ
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000068180:Aripiprazole; D003702:Delusions / Q000150:complications / Q000175:diagnosis; D003865:Major Depressive Disorder / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000209:etiology; D006220:Haloperidol / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D015363:Quinolones / Q000627:therapeutic use*; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole; D006220:Haloperidol